| アブストラクト | The aim of the present study was to examine whether immunohistochemical p53 expression could be identified as an independent predictor for disease recurrence and survival and to assess any relation to tumour type, metastatic potential and response to different therapeutic regimens. We examined gastric carcinomas from 125 patients using a mouse monoclonal antibody (DO7). Seventy two of the tumours showed positive nuclear staining. No special relation was observed either according to tumour type, grade or stage classification of the tumours nor to the lymph node status. Survival analysis showed no significant advantage of the p53 negative patients. Expression of p53 in our series did not prove to be a valuable prognostic marker for survival nor did it correlate with other standard prognostic markers. |
|---|
| ジャーナル名 | Oncology reports |
|---|
| Pubmed追加日 | 1994/11/1 |
|---|
| 投稿者 | Linehan, J; Jader, S; Sanidas, E; Filipe, I; Dunn, J; Levison, D |
|---|
| 組織名 | UNITED MED & DENT SCH,SCH MED,DEPT HISTOPATHOL,LONDON SE1 9RT,ENGLAND. UNIV;BIRMINGHAM,CANC RES CAMPAIGN,TRIALS UNIT,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/21607528/ |
|---|
